Strategic Vision and Infarmed 2026 Priorities f...

By João L. Carapinha

February 12, 2026

Infarmed 2026 Priorities Take Shape in Leadership Summit Infarmed 2026 priorities crystallized during the Executive Board's February 11, 2026, session with unit directors, led...
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
Navigating Economic Resilience Through Life Sciences Investment
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...